An article in the Journal of Hepatology looked at hepatitis B virus reactivation with different immunosuppressants and provides a quick visual guide reviewing the mechanisms of these agents and reactivation risk. Read IDSA’s Journal Club review by Erica Kaufman West, MD.

A study in Lancet Infectious Diseases examined the effectiveness of oral antiviral therapy for COVID-19 in hospitalized, nonhypoxic patients. Read IDSA’s Journal Club review by Erica Kaufman West, MD.

A study in Open Forum Infectious Diseases described a 10-year experience with image-guided biopsy of suspected vertebral osteomyelitis. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.

A study in Clinical Infectious Diseases examined an opt-out intervention protocol to safely reduce antibiotic use in patients with sepsis. Read IDSA’s Journal Club review by A. Krishna Rao, MD, MS.

A study in Nature reported the results of a trial assessing the safety, tolerability and efficacy of two HIV-specific broadly neutralizing monoclonal antibodies. Read IDSA’s Journal Club review by Lauren Richey, MD, MPH, FIDSA.

A study in Open Forum Infectious Diseases examined the duration of therapy and the use of quinolone/rifampin-based regimens after debridement and implant retention for prosthetic joint infections. Read IDSA’s Journal Club review by Aldon Li, MD, FIDSA.

A study in Clinical Microbiology and Infection evaluated clinical outcomes associated with the use of highly bioavailable oral antibiotics compared to less bioavailable oral antibiotics in Gram-negative bloodstream infections. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.

A study in Open Forum Infectious Diseases compared patient outcomes between in-person and telemedicine ID consultative services. Read IDSA’s Journal Club review by Manie Beheshti, MD.

A study in Pediatrics characterized the recovery of pediatric patients with severe COVID-19 or MIS-C and sought to identify factors associated with prolonged symptomatology. Read IDSA’s Journal Club review by Terri Stillwell, MD.

A study in Transplant Infectious Disease assessed the protection afforded by SARS-CoV-2 vaccination against subsequent COVID-19 and severity/mortality. Read IDSA’s Journal Club review by A. Krishna Rao, MD, MS.

A study in the New England Journal of Medicine describes a phase III trial of lenacapavir and suggests the drug may be a promising medication for multidrug-resistant HIV. Read IDSA’s Journal Club review by Lauren Richey, MD, MPH, FIDSA.

A study in JAMA Network Open evaluates whether use of Gram stain results to guide empiric antibiotic therapy for ventilator-associated pneumonia was noninferior to guideline-directed empiric therapy. Read IDSA’s Journal Club review by Milana Bogorodskaya, MD.

A retrospective study in JAMA Internal Medicine compared safety and outcomes of midline catheters vs. peripherally inserted central catheters for patients with short-term indications. Read IDSA’s Journal Club review by Daniel Mendoza, MD.

A small case series reported in Lancet Infectious Diseases describes clinical features and management of monkeypox virus infections in the U.K. Read IDSA’s Journal Club review by Lauren Richey, MD, MPH, FIDSA.

A retrospective cohort study in Antimicrobial Agents and Chemotherapy evaluated the effect of clopidogrel use on the outcomes of patients with Staphylococcus aureus bacteremia. Read IDSA’s Journal Club review by Zeina A. Kanafani, MS, FIDSA.

A case series in Open Forum Infectious Diseases describes real-world use of tedizolid for 28 days or more. Read IDSA’s Journal Club review by Aldon Li, MD, FIDSA.

A retrospective review in Chest highlighted a potential gap in prophylaxis for Pneumocystis jirovecii pneumonia in patients with induced B-cell deficiency. Read IDSA’s Journal Club review by Nirav Patel, MD.

Two recent reports, in Cell and Nature Communications, present evidence for the efficacy of bacteriophage therapies for difficult-to-treat mycobacteria infections. Read IDSA’s Journal Club review by Brendan J. Kelly, MD, MS

A matched cohort study in Clinical Infectious Diseases examined the association of meningitis B vaccine with gonorrhea infection among teens and young adults, and the results suggest cross-protection of the vaccine against gonorrhea. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.

A study in Clinical Infectious Diseases examined the risk of new-onset diabetes mellitus and hyperglycemia in people with HIV who initiated treatment regimens based on integrase strand transfer inhibitors. Read IDSA’s Journal Club review by Krishna Rao, MD, MS.

A study in JAMA Network Open assessed whether continuing dexamethasone treatment at discharge is associated with reduced all-cause readmissions or mortality after discharge for patients hospitalized with COVID-19. Read IDSA’s Journal Club review by Aldon Li, MD, FIDSA.

An article in the American Journal of Infection Control describes a study to determine the effect of discontinuing contact precautions on MRSA hospital-acquired infection rates at a tertiary care center. Read IDSA’s Journal Club review by Zeina Kanafani, MD, MS, FIDSA.

A study in Transplant Infectious Disease looked at the effectiveness of oral vancomycin for C. difficile prophylaxis in allogenic hematopoietic stem cell transplant patients. Read IDSA’s Journal Club review by Erica Kaufman West, MD.

In a study published in Open Forum Infectious Diseases, researchers evaluated the clinical utility of labeled white blood cell scintigraphy in patients undergoing an evaluation of fever of unknown origin. Read IDSA’s Journal Club review by Milana Bogorodskaya, MD.

A study in Infection Control & Hospital Epidemiology provides a cautionary tale of probiotic use in immune-compromised pediatric patients. Read IDSA’s Journal Club review by Terri Stillwell, MD.

A report in Science describes a highly virulent variant of HIV circulating in the Netherlands. Read IDSA’s Journal Club review by Lauren Richey, MD, MPH, FIDSA.

A multicenter study in Transplant Infectious Disease evaluated hepatitis B virus reactivation with and without antiviral prophylaxis after kidney transplantation. Read IDSA’s Journal Club review by Erica Kaufman West, MD.

In JAMA Network Open, researchers recently reported the results of a cohort study to assess a temporal relation between invasive dental procedures and late prosthetic joint infections. Read IDSA’s Journal Club review by Manie Beheshti, MD.

A report in Nature presents an analysis of discrepancies between two large surveys of early COVID-19 vaccine uptake and proposes a novel framework for quantifying survey data quality. Read IDSA’s Journal Club review by Brendan J. Kelly, MD, MS.

Reporting their findings in Clinical Infectious Diseases, researchers analyzed antimicrobial resistance trends in urine E. coli isolates from 2011 to 2019. Read IDSA’s Journal Club review by Daniel Mendoza, MD.

A study in the Morbidity and Mortality Weekly Report offers evidence that COVID-19 vaccination may also provide protection against multisystem inflammatory syndrome in children. Read IDSA’s Journal Club review by Terri Stillwell, MD.

A study in Open Forum Infectious Diseases compared the outcomes of methicillin-resistant Staphylococcus aureus bloodstream infections treated with ceftaroline or daptomycin. Read IDSA’s Journal Club review by A. Krishna Rao, MD, MS.

A study in Clinical Infectious Diseases examined fosfomycin versus ciprofloxacin as oral step-down treatment for E. coli febrile urinary tract infections in women. Read IDSA’s Journal Club review by Aldon Li, MD, FIDSA.

A study in the American Journal of Infection Control described an increase in blood culture contamination during COVID-19 pandemic. Read IDSA’s Journal Club review by Zeina A. Kanafani, MD, MS, FIDSA.

A study in Clinical Infectious Diseases examined the presence of (1→3)-β-D-glucan as a prognostic marker in patients after major abdominal surgery. Read IDSA’s Journal Club review by Nirav Patel, MD.

A study in Clinical Infectious Diseases evaluated whether the sequence of administration of the first dose of antibiotic therapy (a β-lactam or vancomycin) impacts early mortality for patients with bloodstream infections. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.

A study in AIDS examined severe COVID-19 outcomes among people with and without HIV in San Francisco from February 2020 to March 2021. Read IDSA’s Journal Club review by Erica Kaufman West, MD.

A study in AIDS and Behavior compared the health outcomes of people with HIV who inject drugs with people with HIV who only use non-injectable drugs. Read IDSA’s Journal Club review by Milana Bogorodskaya, MD.

A recent article in Clinical Infectious Diseases reported the effectiveness of mRNA vaccines against SARS-CoV-2 infection among health care workers in New York City. Read IDSA’s Journal Club review by Brendan J. Kelly, MD, MS.

A recent article in AIDS and Behavior analyzed experiences with stigma among people with HIV in the U.S. South. Read IDSA’s Journal Club review by Lauren Richey, MD, MPH, FIDSA.

A study in Infection Control & Hospital Epidemiology described the implementation of a short-duration antibiotic therapy algorithm for uncomplicated gram-negative bloodstream infections. Read IDSA’s Journal Club review by A. Krishna Rao, MD, MS.

A study in Clinical Infectious Diseases investigated the impact of 18-fluorine-fluorodeoxyglucose positron emission tomography along with computed tomography on the diagnosis and management of infective endocarditis. Read IDSA’s Journal Club review by Razan El Ramahi, MBBS.

A study in Clinical Infectious Diseases evaluated how inpatient ID telemedicine consults were received by both ID consultants and hospital providers. Read IDSA’s Journal Club review by Erica Kaufman West, MD.

A recent study in JAMA evaluated the effect of longer versus shorter antibiotic durations in afebrile men with urinary tract infections. Read IDSA’s Journal Club review by Manie Beheshti, MD.

A recent study in JAMA Network Open compared the efficacy of a high-dose vaccine schedule with standard dosage for hepatitis B virus revaccination in people with HIV. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.

A recent guideline published in Pediatrics offers an updated approach for the evaluation and management of well-appearing febrile infants 8 to 60 days old. Read IDSA’s Journal Club review by Terri Stillwell, MD.

A recent study in the New England Journal of Medicine estimated the effectiveness of COVID-19 vaccines against the delta variant of SARS-CoV-2. Read IDSA’s Journal Club review by Daniel Mendoza, MD.

A recent study in Antimicrobial Agents and Chemotherapy compared combination therapy consisting of a β-lactam plus an aminoglycoside with β-lactam monotherapy in hematological neutropenic patients with gram-negative bloodstream infections. Read IDSA’s Journal Club review by Milana Bogorodskaya, MD.

A recent study in Clinical Infectious Diseases analyzed transmitted HIV drug resistance trends in the U.S. from 2014 to 2018. Read IDSA’s Journal Club review by Lauren Richey, MD, MPH, FIDSA.

A study in Open Forum Infectious Diseases compared mortality between patients with enterococcal infective endocarditis treated with ampicillin-ceftriaxone or ampicillin-gentamicin. Read IDSA’s Journal Club review by A. Krishna Rao, MD, MS.

A study in JAMA Internal Medicine sought to externally validate a widely implemented proprietary sepsis prediction model in hospitalized patients. Read IDSA’s Journal Club review by Nirav Patel, MD.

A recent study in Transplant Infectious Disease described COVID-19 outcomes in solid organ transplant recipients. Read IDSA’s Journal Club review by Erica Kaufman West, MD.

A recent study in Clinical Infectious Diseases compared the outcomes of patients with bloodstream infections due to metallo-β-lactamase–producing Enterobacterales treated either with ceftazidime-avibactam plus aztreonam or other active antibiotics. Read IDSA’s Journal Club review by Manie Beheshti, MD.

A recent study in Annals of Internal Medicine compared the effectiveness and safety of amoxicillin-clavulanate to a metronidazole-fluoroquinolone combination in adults with diverticulitis treated as outpatients. Read IDSA’s Journal Club review by Zeina A. Kanafani, MD, MS, FIDSA.

A recent study in Clinical Infectious Diseases described the use of an antibiotic cross-reactivity chart to improve the prescribing of β-lactam antibiotics for surgical prophylaxis. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.

A new study in Critical Care Medicine evaluated the association between antibiotic delay intervals and hospital mortality among patients treated in the emergency department for suspected sepsis. Read IDSA’s Journal Club review by Nirav Patel, MD.

A recent study in Open Forum Infectious Diseases investigated bone mineral density screening among people with HIV. Read IDSA’s Journal Club review by Lauren Richey, MD, MPH, FIDSA.

A recent Lancet study looked at 3 days versus 8 days of β-lactam therapy for community-acquired pneumonia. Read IDSA’s Journal Club review by Razan El Ramahi, MBBS.

A recent analysis in Antimicrobial Agents and Chemotherapy examined whether procalcitonin can distinguish between bacterial coinfection and the inflammatory response caused by COVID-19. Read IDSA’s Journal Club review by Zeina A. Kanafani, MD, MS, FIDSA.

A new article in Clinical Infectious Diseases reports on the addition of metronidazole in the treatment of pelvic inflammatory disease. Read IDSA’s Journal Club review by Manie Beheshti, MD.

A recent study in Clinical Infectious Diseases evaluated a shorter course of therapy for methicillin-susceptible S. aureus bacteremia. Read IDSA’s Journal Club review by Erica Kaufman West, MD.

A recent study in Clinical Infectious Diseases estimated the risk of C. difficile infection associated with specific antibiotic regimens. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.

A recent study examined risk factors and outcomes of BK virus in pediatric stem cell transplant recipients. Read IDSA’s Journal Club review by Terri Stillwell, MD.

A recent CID study evaluated the effectiveness of 3 feet versus 6 feet of physical distancing for controlling the spread of COVID-19 in schools. Read IDSA’s Journal Club review by A. Krishna Rao, MD, MS.

A Lancet study compared the use of injectable cabotegravir and rilpivirine every 8 weeks to treat HIV compared with dosing every 4 weeks. Read IDSA’s Journal Club review by Lauren Richey, MD, MPH, FIDSA.

A study in Infection Control & Hospital Epidemiology evaluated the impact of the COVID-19 pandemic on device-associated infections in hospitals. Read IDSA’s Journal Club review by Nirav Patel, MD.

A recent study in the New England Journal of Medicine examined antibody status and the incidence of SARS-CoV-2 infection in health care workers. Read IDSA’s Journal Club review by Razan El Ramahi, MBBS.

A recent study evaluated linezolid pharmacokinetics in critically ill obese patients with severe skin and soft tissue infections. Read IDSA’s Journal Club review by Zeina Kanafani, MD, MS, FIDSA.

A recent study in JAMA Network Open examined the effect of zinc and ascorbic acid on SARS-CoV-2 symptoms compared to usual care. Read IDSA’s Journal Club review by Erica Kaufman West, MD.

A recent CID study described the benefits and harms of antibiotic prophylaxis for urinary tract infections in older adults. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.

Two studies in the Morbidity and Mortality Weekly Report characterized COVID-19 trends in younger individuals and analyzed infection rates within schools. Read IDSA’s Journal Club review by Terri Stillwell, MD.

A study in Critical Care Medicine evaluated long-term sustainability and acceptance of antimicrobial stewardship in intensive care. Read IDSA’s Journal Club review by Milana Bogorodskaya, MD.

A Critical Care Medicine study evaluated the diagnostic yield of routine admission blood cultures in critically ill patients. Read IDSA’s Journal Club review by Kelly Cawcutt, MD, MS, FIDSA.

A study in Clinical Microbiology and Infection examined the utility of follow-up blood cultures in gram-negative bacteremia. Read IDSA’s Journal Club review by Lauren Richey, MD, MPH, FIDSA.

A JAMA Internal Medicine research letter analyzed asymptomatic and presymptomatic SARS-CoV-2 infection rates in skilled nursing facilities. Read IDSA’s Journal Club review by Erica Kaufman West, MD.

A recent American Journal of Infection Control study assessed the effect of stopping contact precautions for MRSA and VRE. Read IDSA’s Journal Club review by Zeina A. Kanafani, MD, MS, FIDSA.

A recent study evaluated the potential role of PET/CT scans in the diagnostic workup for S. aureus bacteremia. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.

Two recent publications describe long-term outcomes in patients hospitalized with COVID-19. Read IDSA’s Journal Club review by Milana Bogorodskaya, M.D.

A recent study in Science explored the role of autoantibodies against type I interferons in patients with critical COVID-19. Read IDSA’s Journal Club review by Daniel Mendoza, M.D., Ph.D.

Trial results for long-acting injectable cabotegravir and rilpivirine for HIV maintenance therapy were recently reported in the Journal of Acquired Immune Deficiency Syndrome. Read IDSA’s Journal Club review by Lauren Richey, M.D., MPH, FIDSA.

A recent article in Critical Care Medicine reported the results of a survey of intensive care unit clinicians about managing COVID-19 patients, resource demands, and personal stress. Read IDSA’s Journal Club review by Nirav Patel, M.D.

A recent article in Eurosurveillance evaluated the relationship between RT-PCR cycle threshold values and the duration of COVID-19 infectiousness. Read IDSA’s Journal Club review by Zeina A. Kanafani, M.D., MS, FIDSA.

A recent article in Lancet Oncology examined tumor type and the risk of infection with and death from SARS-CoV-2. Read IDSA’s Journal Club review by Razan El Ramahi, M.B.B.S.

A recent OFID article described clinical characteristics and outcomes based on race of hospitalized patients with COVID-19 in New Orleans. Read IDSA’s Journal Club review by Erica Kaufman West, M.D.

As the COVID-19 pandemic continues to evolve, ongoing understanding of behavioral risks of infection acquisition remains critically important in informing public health measures and messaging.

In a recent Lancet Public Health study, Nguyen et al. assessed the risk of COVID-19 among front-line health care workers (HCWs) compared with the general population and the effect of personal protective equipment (PPE) on this risk in the U.K. and U.S.

A recent Annals of Internal Medicine article evaluated the risk of SARS-CoV-2 transmission to close contacts in different settings. Read IDSA’s Journal Club review by Kelly Cawcutt, M.D., MS.

Recent articles in the Journal of Acquired Immune Deficiency Syndromes and CID described COVID-19 outcomes in people with HIV. Read IDSA’s Journal Club review by Lauren Richey, M.D., MPH, FIDSA.

A recent Lancet Rheumatology article investigated the use of tocilizumab in patients with severe COVID-19. Read IDSA’s Journal Club review by Razan El Ramahi, M.B.B.S.

A recent article in Clinical Infectious Diseases described the demographics of SARS-CoV-2 infection in the New York City area. Read IDSA’s Journal Club review by Christopher J. Graber, M.D., MPH, FIDSA.

A recent study in JAMA Network Open looked at colchicine as an anti-inflammatory treatment for COVID-19. Read IDSA’s Journal Club review by Erica Kaufman West, M.D.

A recent study in the Proceedings of the National Academy of Sciences explored the genomic determinants of SARS-CoV-2 pathogenicity and transmission. Read IDSA’s Journal Club review by Jennifer Brown, M.D.

Several recent articles have described cases of multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2. Read IDSA’s Journal Club review by Terri Stillwell, M.D.

A recent Lancet article investigated the effects of distancing, face masks, and eye protection on SARS-CoV-2 transmission. Read IDSA’s Journal Club review by Kelly Cawcutt, M.D., MS.

Two recent publications have provided initial data on the toll of COVID-19 on health care personnel. Read IDSA’s Journal Club review by Manie Beheshti, M.D.

Journal Club COVID-19 Edition: Radiological Manifestations in Patients with COVID-19

Journal Club COVID-19 Edition: Lessons Learned From COVID-19 Contact Tracing in Taiwan

Journal Club COVID-19 Edition: Convalescent Plasma for Critically Ill Patients with COVID-19

IDSA News COVID-19 Special Edition

COVID-19 Statements, Testing Resources, Podcasts and More

Federal Funding for COVID-19, CMS Release SAR-CoV-2 Billing Code, Society Awards Nominations Opens, and More

Apply for Board of Directors, Become an IDSA Fellow, President's Budget Increase, and More

Updated Coronavirus Resources, Apply for the Board of Directors, New Guidelines App, and More

Wuhan nCoV Resources Available on IDSA Website, 31st Annual Clinical Fellows Meeting, and More.

Bankruptcies Fuel AMR Crisis, Congress Funds “Ending the HIV Epidemic,” and More

2019 Achievements, ID Match Results, FY 2020 Fed Spending Bill

Stewardship Podcast, HCV Guidance Updates, GERM Program Accepting Applications

IDSA is Thankful for You, Our Members, New TB Guideline, $500k Research Grants Available

CDC's AMR Threat Report, Meet IDSA’s New President, CMS Issues Final E/M Code Revisions, and more.

LEAP Fellowship Announced, IDSA Hosts Research Summit, Public Health Concerns Over Immigrant Detention Centers.

New Strategic Plan, IDWeek Breaks Records, 2020 IDSA Leadership Institute, & More.

Board of Directors, Society Awards, IDWeek Twitterstorm, and More

Gender Advancement Barriers Focus Groups, Twitterstorm on Vaccines, Journal Club and More!

Take the ID/HIV Compensation Survey Today, 2019 FIDSA Designees, Leadership Institute Application Opens Soon, and more!

Sneak Preview of IDWeek Lecturers, New Core Antimicrobial Stewardship Curriculum, Journal Club, and More!

ID Physician Compensation Survey, Medicare Physician Fee Schedule Proposed Rule, Journal Club, and More!

ID Physician Compensation Survey, IDWeek Mentorship Program, HIV Provider Directory, and More.

ID Physician Compensation Survey, Centers of Excellence Designation, and More.

2019 IDSA/HIVMA Board of Directors Elections Now Underway, The New IDSA Academy Is Here, and More.

New Legislation Will #DISARMSuperbugs, Spring Break for ID Doctors?, Urge Congress to Support the VACCINES Act, and More

IDSA at the World Health Assembly, Join the HIV Provider Directory, Urge Presidential Candidates to Prioritize ID & HIV, and more.

Inaugural Leadership Institute, Clinical Fellows Meeting Planning Volunteer Opportunity, A Journey Toward Inclusion, Diversity, Access & Equity at IDSA, and more.

Measles Cases Reach Record Numbers, IDSA Member ACP Award Recipients, New Learning Management System and More.

New IDSA Patient Fact Sheet, Take Action to Fully Fund ID/HIV Programs, Call for Committee Volunteers Deadline Approaching, and more.

Call for Committee Volunteers, Become an Advocate for ID & HIV, ID & the Opioid Epidemic, and more.

Leadership Development Committee Members Named, 2018 Annual Report, Journal Club, and more.

FIDSA Applications, Society Awards Nominations, IDWeek Registration Open, and more.

Deadline Approaching: BoD Applications, ALZ Grant Awardees, Journal Club and more.

State of the Union Response, Board of Directors Call for Applications, Journal Club and more

In Memoriam: Dr. Gerald Medoff, Vaccine Advocacy Toolkit, Journal Club and more

Leadership Development Committee, Government Shutdown, Journal Club, and more

Updated IDSA Flu Guidelines, Bylaws Vote, Journal Club and more

Embrace the Future of ID, NIAID Revises FY19 K Award Payline, Journal Club, and more

Embrace the Future of ID, NIAID Revises FY19 K Award Payline, Journal Club, and more

Important Bylaws Vote, New OPAT Guideline, CMS Final Rule on E/M Code

Improvements to Guidelines on Website, ABIM Announces Changes, Journal Club and more

IDWeek 2018 Highlights, IDSA Launches Leadership Institute, ABIM Prep for Changes in 2019, and more

IDWeek 2018 Special Edition

In Memoriam: Sid Finegold, MD, FIDSA; Diversity, Inclusion & Equity Task Force Members Named; Journal Club & More

Hurricane Preparations, Efforts to Delay E/M Code Change Gain Traction on the Hill, Journal Club & More

Announcing 2018 FIDSAs, Protecting LTDs, IDSA in the News and more

Optimizing the ID Physician-Scientist Workforce, Potentially Harmful Proposed E/M Code Changes

Guidelines Survey, ABIM Governance, Journal Club and more

Alzheimer’s Research Funding Opp, ABIM Knowledge Check-in Feedback

Updated Lab Diagnosis Guide; Journal Club; Governance Recommendations

In Memoriam of Adel Mahmoud, MD, PhD, FIDSA

2018 IDSA/HIVMA Elections

“Outbreak” Exhibit Debuts at Smithsonian

In Memoriam: Stanley Falkow; Webinar: Discussing Journals

Calling All Innovators; Become an Advocate; ASP Curriculum; Fighting TB & More